Drug Shortage Report for CLADRIBINE INJECTION
Report ID | 127210 |
Drug Identification Number | 02319918 |
Brand name | CLADRIBINE INJECTION |
Common or Proper name | Cladribine Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CLADRIBINE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | mg/mL SD Vial, 10 mL |
ATC code | L01BB |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-10-30 |
Actual start date | |
Estimated end date | 2020-11-16 |
Actual end date | 2020-11-16 |
Shortage status | Resolved |
Updated date | 2021-01-26 |
Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a delay in shipment, we will be encountering a supply interruption on our Cladribine Injection, 1 mg/mL SD Vial, 10 mL. Please note the product will remain on 100% allocation until stock is depleted. UPDATE Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Cladribine Injection, 1 mg/mL, SD Vial, 10 mL have been released and will be available at all distribution centers across the country early next week November 16, 2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-01-26 | French | Compare |
v4 | 2021-01-26 | English | Compare |
v3 | 2020-10-31 | English | Compare |
v2 | 2020-10-27 | French | Compare |
v1 | 2020-10-27 | English | Compare |
Showing 1 to 5 of 5